IFP Advisors’s aTyr Pharma ATYR Stock Holding History

IFP Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85	Sell	143 -5,858	-98%	-$3.83K	﹤0.01%	4978
2026 Q1	$4.68K	Buy	+6,001	New	+$5.07K	﹤0.01%	3566
2017 Q2	–	Sell	-36	Closed	-$2K	–	4239
2017 Q1	$2K	Hold	36	–	–	﹤0.01%	3707
2016 Q4	$1K	Hold	36	–	–	﹤0.01%	3864
2016 Q3	$2K	Sell	36 -71	-66%	-$3.07K	﹤0.01%	3629
2016 Q2	$4K	Buy	+107	New	+$4.97K	﹤0.01%	3274

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFP Advisors's ATYR Position: Q2 2026 in Review

IFP Advisors reduced its aTyr Pharma (ATYR) stake by 98% in Q2 2026, selling an estimated $3.83K and leaving 143 shares worth $85. The position accounts for ﹤0.01% of the portfolio, ranked #4978.

IFP Advisors first reported a position in ATYR in Q2 2016 and has held it in 6 quarters since. The position peaked at $4.68K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

IFP Advisors held 143 shares of aTyr Pharma worth $85 as of Q2 2026.
IFP Advisors sold 5,858 aTyr Pharma shares in Q2 2026, an estimated $3.83K.
aTyr Pharma made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4978 holding.
IFP Advisors first reported a position in aTyr Pharma in Q2 2016 and has held it in 6 quarters since.
IFP Advisors's aTyr Pharma position peaked at $4.68K in Q1 2026.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.